Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
about
Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluationA systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option.Bilateral angle-closure glaucoma in a young female receiving cabergoline: a case reportNose-To-Brain Delivery of PLGA-Diazepam NanoparticlesDesign and evaluation of mucoadhesive microemulsion for neuroprotective effect of ibuprofen following intranasal route in the MPTP mice model.Preclinical Study of Ibuprofen Loaded Transnasal Mucoadhesive Microemulsion for Neuroprotective Effect in MPTP Mice Model.
P2860
Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
@ast
Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
@en
Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
@nl
type
label
Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
@ast
Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
@en
Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
@nl
prefLabel
Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
@ast
Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
@en
Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
@nl
P2093
P2860
P1433
P1476
Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
@en
P2093
Anil Kumar Mishra
Gitanjali Sharma
Pushpa Mishra
P2860
P2888
P304
P356
10.1208/S12249-009-9329-8
P407
P577
2009-11-06T00:00:00Z
P5875
P6179
1017941869